all

All-trans-Anhydro Retinol (Anhydrovitamin A) is a Vitamin A metabolite commonly employed in the synthesis of multivitamin preparations[1].

All-cis-4,7,10,13,16-Docosapentaenoic acid (all-cis-4,7,10,13,16-DPA) methyl ester, also known as Osbond acid, is an isomer of DPA and a more lipid-soluble variant of the free acid, primarily found in fish oils as an ω-3, 22-carbon fatty acid. Despite being an ω-6 fatty acid synthesized through the elongation and desaturation of arachidonic acid, its levels can decrease due to fatty acid desaturase syndrome, potentially impacting development. Additionally, increased expression of hepatic elongation of very long fatty acids protein 6 and elevated levels of very long-chain fatty acids, including all-cis-4,7,10,13,16-DPA, are indicative of nonalcoholic steatohepatitis, a condition that precedes hepatocellular carcinoma.

All-cis-4,7,10,13,16-Docosapentaenoic acid ethyl ester (all-cis-4,7,10,13,16-DPA ethyl ester) is a derivative of docosapentaenoic acid (DPA), an omega-3 fatty acid prevalent in fish oils. This ethyl ester form is commonly included in dietary supplements formulations to enhance omega-3 fatty acid intake.

3(S)-Hydroxy-docosa-10,13,16,19-all-cis-tetraenoyl-CoA (3(S)-Hydroxy-docosa-10,13,16,19-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-tetracosa-9,12,15,18,21-all-cis-pentaenoyl-Co (3(S)-Hydroxy-tetracosa-9,12,15,18,21-all-cis-pentaenoyl-coenzyme A) is a derivative of coenzyme A.

2-trans-7,10,13,16,19-all-cis-Docosahexaenoyl-CoA (2-trans-7,10,13,16,19-all-cis-Docosahexaenoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-docosa-7,10,13,16-all-cis-tetraenoyl-CoA (3(S)-Hydroxy-docosa-7,10,13,16-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-tetracosa-6,9,12,15,18-all-cis-pentaenoyl-CoA (3(S)-Hydroxy-tetracosa-6,9,12,15,18-all-cis-pentaenoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-10,13,16-all-cis-docosatrienoyl-CoA (3(S)-Hydroxy-10,13,16-all-cis-docosatrienoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA (3(S)-Hydroxy-docosa-7,10,13,16,19-all-cis-pentaenoyl-coenzyme A) is a derivative of coenzyme A.

2-trans-9,12,15,18-all-cis-Tetracosapentaenoyl-CoA (2-trans-9,12,15,18-all-cis-Tetracosapentaenoyl-coenzyme A) is a derivative of coenzyme A.

3(S)-Hydroxy-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA (3(S)-Hydroxy-tetracosa-12,15,18,21-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

2-trans-9,12,15,18,21-all-cis-Tetracosahexaenoyl-CoA (2-trans-9,12,15,18,21-all-cis-Tetracosahexaenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-docosa-7,10,13,16,19-all-cis-pentaenoyl-CoA (3-Oxo-docosa-7,10,13,16,19-all-cis-pentaenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-tetracosa-9,12,15,18-all-cis-tetraenoyl-CoA (3-Oxo-tetracosa-9,12,15,18-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-tetracosa-12,15,18,21-all-cis-tetraenoyl-CoA (3-Oxo-tetracosa-12,15,18,21-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-docosa-10,13,16,19-all-cis-tetraenoyl-CoA (3-Oxo-docosa-10,13,16,19-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-all-cis-6,9,12,15,18-tetracosapentaenoyl-CoA (3-Oxo-all-cis-6,9,12,15,18-tetracosapentaenoyl-coenzyme A) is a derivative of coenzyme A.

3-Oxo-docosa-7,10,13,16-all-cis-tetraenoyl-CoA (3-Oxo-docosa-7,10,13,16-all-cis-tetraenoyl-coenzyme A) is a derivative of coenzyme A.

All-cis-10,13,16,19-Docosatetraenoyl-CoA (all-cis-10,13,16,19-Docosatetraenoyl-coenzyme A) is a derivative of coenzyme A.

Trans-2-all-cis-6,9,12,15,18-Tetracosahexaenoyl-CoA (trans-2-all-cis-6,9,12,15,18-Tetracosahexaenoyl-coenzyme A) is a derivative of coenzyme A.

All-trans-retinal (Vitamin A aldehyde) is a one of the major vitamin A metabolites in the retina. All-trans-RAL is regenerated to the visual chromophore, 11-cis-retinal in physiological conditions.

all-trans-4-Oxoretinoic acid (all-trans 4-Keto Retinoic Acid) is an active metabolite of vitamin A.

Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction with Ki of 0.149 nM and IC50 between 10 and 20 nM, which can be used in the study of acute leukemia with MLL gene rearrangement.